Gilead’s Kite bags option to buy gamma delta startup Gadeta

Gilead’s Kite bags option to buy gamma delta startup Gadeta

Source: 
Fierce Biotech
snippet: 

Gilead’s Kite Pharma has snagged an option to buy gamma delta T-cell receptor (TCR) startup Gadeta. The deal sees Kite take a stake in Gadeta and commit to milestones tied to the progress of oncology candidates.